T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$1.6B |
| 2 |
Verizon
VZ
|
+$1.3B |
| 3 |
US Bancorp
USB
|
+$1.26B |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$1.26B |
| 5 |
Lam Research
LRCX
|
+$1.18B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$6.33B |
| 2 |
Tesla
TSLA
|
+$5.64B |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$4.91B |
| 4 |
TMX
Terminix Global Holdings, Inc.
TMX
|
+$3.44B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.4B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.7% |
| 2 | Healthcare | 19.64% |
| 3 | Financials | 12.71% |
| 4 | Consumer Discretionary | 10.95% |
| 5 | Communication Services | 7.77% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
UTAA
1926
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
| $750K | ﹤0.01% |
+73,500
| New | +$744K |
|
1927
Kennametal
KMT
$2.35B
| $748K | ﹤0.01% |
31,075
-11,517
| -27% | -$285K |
|
1928
Center Bancorp
CNOB
$1.81B
| $747K | ﹤0.01% |
30,846
+4,043
| +15% | +$99.4K |
|
|
ACH
1929
Accendra Health
ACH
$84.6M
| $743K | ﹤0.01% |
38,036
+2,747
| +8% | +$53.6K |
|
1930
Clear Secure
YOU
$4.75B
| $742K | ﹤0.01% |
27,063
+17,025
| +170% | +$469K |
|
1931
Cerence
CRNC
$391M
| $741K | ﹤0.01% |
39,971
+5,501
| +16% | +$94.2K |
|
1932
Benchmark Electronics
BHE
$2.94B
| $740K | ﹤0.01% |
27,735
-6,088
| -18% | -$168K |
|
1933
Andersons Inc
ANDE
$2.21B
| $738K | ﹤0.01% |
21,088
-406
| -2% | -$14.4K |
|
|
DEA
1934
Easterly Government Properties
DEA
$1.16B
| $738K | ﹤0.01% |
20,698
+501
| +2% | +$19.5K |
|
1935
Aclaris Therapeutics
ACRS
$860M
| $736K | ﹤0.01% |
46,712
-394
| -0.8% | -$6.34K |
|
|
RETA
1936
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $736K | ﹤0.01% |
19,369
+323
| +2% | +$11.1K |
|
1937
Astrana Health
ASTH
$1.78B
| $735K | ﹤0.01% |
24,827
+3,248
| +15% | +$104K |
|
|
BNR
1938
Burning Rock Biotech
BNR
$105M
| $734K | ﹤0.01% |
32,636
-1,290
| -4% | -$29.4K |
|
|
INFN
1939
DELISTED
Infinera Corporation Common Stock
INFN
| $733K | ﹤0.01% |
108,720
-1,515
| -1% | -$9.19K |
|
|
ONTF
1940
DELISTED
ON24
ONTF
| $731K | ﹤0.01% |
84,595
-133,077
| -61% | -$1.07M |
|
1941
MannKind Corp
MNKD
$1.24B
| $730K | ﹤0.01% |
138,566
+5,372
| +4% | +$22K |
|
|
FFIC
1942
DELISTED
Flushing Financial
FFIC
| $728K | ﹤0.01% |
37,555
+3,310
| +10% | +$66.6K |
|
1943
National Beverage
FIZZ
$2.9B
| $727K | ﹤0.01% |
15,633
+800
| +5% | +$37.5K |
|
1944
Laureate Education
LAUR
$5.1B
| $727K | ﹤0.01% |
75,571
+6,825
| +10% | +$73.7K |
|
1945
Douglas Dynamics
PLOW
$981M
| $727K | ﹤0.01% |
20,112
+4,457
| +28% | +$157K |
|
1946
Viridian Therapeutics
VRDN
$2.49B
| $727K | ﹤0.01% |
24,894
+7,340
| +42% | +$169K |
|
1947
Univest Financial
UVSP
$1.18B
| $726K | ﹤0.01% |
27,766
-564
| -2% | -$15.1K |
|
1948
West Bancorporation
WTBA
$503M
| $725K | ﹤0.01% |
28,380
+4,563
| +19% | +$105K |
|
1949
Cannae Holdings
CNNE
$675M
| $724K | ﹤0.01% |
35,081
-1,816
| -5% | -$39.7K |
|
1950
Veracyte
VCYT
$3.59B
| $722K | ﹤0.01% |
30,408
-926
| -3% | -$21.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2022 Portfolio in Review
As of Q4 2022, T. Rowe Price Associates held 3,066 positions worth $622B, up 1.8% from $610B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
T. Rowe Price Associates's Q4 2022 filing shows 113 new, 1,569 increased, 1,081 reduced and 107 closed positions. Its largest new stake was GE HealthCare: 6,360,001 shares worth $371M. The largest sale was Amazon, an estimated $6.33B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2022 buy was GE HealthCare: 6,360,001 shares worth $371M.
- T. Rowe Price Associates added most to JPMorgan Chase in Q4 2022, an estimated $1.6B increase.
- T. Rowe Price Associates's biggest Q4 2022 reduction was Amazon, cutting an estimated $6.33B.
- T. Rowe Price Associates fully exited Terminix Global Holdings, Inc. in Q4 2022, selling an estimated $3.44B.
- T. Rowe Price Associates's ten largest holdings make up 27% of its $622B portfolio in Q4 2022.
- T. Rowe Price Associates opened 113 new positions and closed 107 in Q4 2022.
- T. Rowe Price Associates's portfolio value rose 1.8% quarter-over-quarter to $622B.
Based on T. Rowe Price Associates's 13F filing for Q4 2022, filed 14 Feb 2023.